Sa-jia Sun1, Long Feng, Guo-qiang Zhao, Zi-ming Dong. 1. Department of Pathophysiology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China. sajia_sun2010@yahoo.com.cn
Abstract
BACKGROUND: HAX-1 is an anti-apoptotic factor and regulates the expression of DNA pol β. Interestingly, DNA polymerase pol β is overexpressed in esophageal squamous cell carcinoma (ESCC). However, the functional role of HAX-1 in ESCC remains unclear. AIMS: To investigate the role of HAX-1 in chemoresistance, invasion, and tumorigenicity of ESCC. METHODS: Lentivirus-mediated overexpression or knockdown of HAX-1 was employed to establish ESCC EC9706 cell lines that expressed HAX-1 at different levels. The biological behaviors of these engineered cells were characterized in vitro and in vivo using a xenograft nude mice model. In addition, HAX-1 and pol β expression in the tumor tissues was detected by RT-PCR and immunohistochemistry. RESULTS: HAX-1 overexpression promoted cell proliferation and resistance against cisplatin, increased cell invasion and suppressed apoptosis along with increased pol β expression. Conversely, HAX-1 knockdown inhibited the malignant phenotypes of EC9706 cells. The xenograft nude mice model demonstrated that HAX-1 overexpression or depletion led to increased or decreased tumor growth in vivo, respectively. Furthermore, a positive correlation of HAX-1 and pol β expression in the tumor tissues was observed. CONCLUSIONS: HAX-1 promotes the proliferation, chemoresistance, invasion, and tumorigenicity of ESCC, and this is correlated with increased poly β expression. HAX-1 may represent a potential target to overcome the resistance and metastasis of ESCC.
BACKGROUND:HAX-1 is an anti-apoptotic factor and regulates the expression of DNA pol β. Interestingly, DNA polymerase pol β is overexpressed in esophageal squamous cell carcinoma (ESCC). However, the functional role of HAX-1 in ESCC remains unclear. AIMS: To investigate the role of HAX-1 in chemoresistance, invasion, and tumorigenicity of ESCC. METHODS: Lentivirus-mediated overexpression or knockdown of HAX-1 was employed to establish ESCC EC9706 cell lines that expressed HAX-1 at different levels. The biological behaviors of these engineered cells were characterized in vitro and in vivo using a xenograft nude mice model. In addition, HAX-1 and pol β expression in the tumor tissues was detected by RT-PCR and immunohistochemistry. RESULTS:HAX-1 overexpression promoted cell proliferation and resistance against cisplatin, increased cell invasion and suppressed apoptosis along with increased pol β expression. Conversely, HAX-1 knockdown inhibited the malignant phenotypes of EC9706 cells. The xenograft nude mice model demonstrated that HAX-1 overexpression or depletion led to increased or decreased tumor growth in vivo, respectively. Furthermore, a positive correlation of HAX-1 and pol β expression in the tumor tissues was observed. CONCLUSIONS:HAX-1 promotes the proliferation, chemoresistance, invasion, and tumorigenicity of ESCC, and this is correlated with increased poly β expression. HAX-1 may represent a potential target to overcome the resistance and metastasis of ESCC.
Authors: Yuchi Han; Yee-Shiuan Chen; Zhilin Liu; Natalya Bodyak; Debra Rigor; Egbert Bisping; William T Pu; Peter M Kang Journal: Circ Res Date: 2006-07-20 Impact factor: 17.367
Authors: Nan Hu; Chaoyu Wang; David Ng; Robert Clifford; Howard H Yang; Ze-Zhong Tang; Quan-Hong Wang; Xiao-You Han; Carol Giffen; Alisa M Goldstein; Philip R Taylor; Maxwell P Lee Journal: Cancer Res Date: 2009-07-07 Impact factor: 12.701
Authors: Alan G Ramsay; Melanie D Keppler; Mona Jazayeri; Gareth J Thomas; Maddy Parsons; Shelia Violette; Paul Weinreb; Ian R Hart; John F Marshall Journal: Cancer Res Date: 2007-06-01 Impact factor: 12.701
Authors: Luciana M Fontanari Krause; Anna Sophia Japp; Alexandre Krause; Jana Mooster; Martin Chopra; Markus Müschen; Stefan K Bohlander Journal: Sci Rep Date: 2014-10-09 Impact factor: 4.379